Anumana wins FDA clearance for ECG-AI algorithm
Related Articles
New Ventures To Use AI To Target Heart Disease
Innovator News: Mayo Clinic announced a new technology platform and launched two new companies April 14 that promise to improve doctors’ ability to spot disease early by connecting data from…{post_date: F d, Y}
The Real Test for AI Diagnostics Isn’t Performance — It’s Clinical Adoption
Cardiology, in particular, offers a clear view into why so many AI solutions struggle to scale and what differentiates those that are poised for adoption. Across healthcare, AI-enabled diagnostic solutions…{post_date: F d, Y}
Anumana, Pfizer collaborate on AI-based detection of cardiovascular disease
NS Medical Devices: The research agreement with Pfizer will aid Anumana to develop an AI-enabled ECG algorithm to help detect patients who may be at risk of cardiac amyloidosis{post_date: F d, Y}
How Doctors Use AI to Help Diagnose Patients
Wall Street Journal: At Mayo cardiology, an AI tool has helped doctors diagnose new cases of heart failure and cases of irregular heart rhythms, which are called atrial fibrillation, potentially…{post_date: F d, Y}